The DNAL1 Knockout HEK293T Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population in which the DNAL1 gene has been functionally disrupted. This loss-of-function model serves as a versatile tool for investigating the role of the axonemal dynein light chain DNAL1 in ciliary motility and associated cellular processes. By ablating DNAL1 expression, researchers can explore its contributions to outer dynein arm assembly, intraflagellar transport, and ciliary beat regulation within a tractable epithelial cell background.
The HEK293T parental cell line is a human embryonic kidney epithelial line transformed with SV40 large T antigen, widely employed for robust protein overexpression and lentivirus production. Although HEK293T cells are not typically ciliated under standard culture conditions, ciliogenesis can be induced via serum starvation or specific protocols, enabling the study of ciliary proteins. This host provides a simplified, genetically accessible platform free from the complexity of multiciliated epithelia, making it ideal for dissecting early steps in ciliary protein complex formation.
DNAL1 encodes a light chain component of the outer dynein arm in motile cilia and flagella, essential for force generation and motility. It directly interacts with heavy chain DNAH5 and intermediate chain DNAI1, forming functional dynein complexes that drive axonemal bending. Upstream transcription factors RFX family members and FoxJ1, along with Notch signaling, regulate DNAL1 expression. Downstream, DNAL1 disruption impairs ciliary beat frequency and mucociliary clearance, and affects axoneme integrity through interactions with tubulin, radial spoke head proteins, and IFT complex components.
In HEK293T cells, DNAL1 knockout creates a simplified model to study outer dynein arm assembly and ciliary protein networking without the complexity of multiciliated tissues. It allows researchers to examine how loss of DNAL1 perturbs dynein complex formation and its interactions with tubulin and other axonemal proteins. This system is particularly valuable for uncovering mechanisms underlying primary ciliary dyskinesia (PCD) and related ciliopathies, where DNAL1 mutations lead to defective motility.
Applications include screening for ciliopathy modifiers, evaluating gene therapy vectors designed to restore ciliary function, and characterizing DNAL1 protein interactions under ciliated conditions. Representative assays involve western blotting to confirm DNAL1 ablation and assess levels of interacting partners like DNAH5 and DNAI1, co-immunoprecipitation to probe dynein complex integrity, immunofluorescence for acetylated tubulin to visualize cilia, and RT-qPCR for ciliogenesis markers. This knockout population provides a robust platform for functional studies of ciliary motility and disease modeling. For further technical details or customized solutions, please contact Ascent Research.
